rhNGF eye drop solution

recombinant human nerve growth factor · Dompé Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhNGF eye drop solution, covering 2026-02-13 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease. [Phase 2]

See pricing